LOCUS BT020002 1047 bp mRNA linear HUM 28-OCT-2004 DEFINITION Homo sapiens Putative prostate cancer tumor suppressor mRNA, complete cds. ACCESSION BT020002 VERSION BT020002.1 KEYWORDS FLI_CDNA. SOURCE Homo sapiens (human) ORGANISM Homo sapiens Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; Homo. REFERENCE 1 (bases 1 to 1047) AUTHORS Kalnine,N., Chen,X., Rolfs,A., Halleck,A., Hines,L., Eisenstein,S., Koundinya,M., Raphael,J., Moreira,D., Kelley,T., LaBaer,J., Lin,Y., Phelan,M. and Farmer,A. TITLE Cloning of human full-length CDSs in BD Creator(TM) System Donor vector JOURNAL Unpublished REFERENCE 2 (bases 1 to 1047) AUTHORS Kalnine,N., Chen,X., Rolfs,A., Halleck,A., Hines,L., Eisenstein,S., Koundinya,M., Raphael,J., Moreira,D., Kelley,T., LaBaer,J., Lin,Y., Phelan,M. and Farmer,A. TITLE Direct Submission JOURNAL Submitted (28-OCT-2004) BD Biosciences Clontech, 1020 East Meadow circle, Palo Alto, California 94303, USA COMMENT This CDS clone is a part of a collection of human full length expression clones generated by BD Biosciences Clontech and the Harvard Institute of Proteomics. Each CDS has been cloned in two forms: with and without stop-codon (to allow fusion with C-terminal tag). The CDS has been directionally cloned using BD In-Fusion(TM) cloning system between the SalI and HindIII sites of the pDNR-DUAL vector. Additional sequences in the clone: 'ACC' after SalI site and before 'ATG' to provide Kozak consensus sequence; 'GG' after last codon and before HindIII site to maintain reading frame. Clone distribution: http://bioinfo.clontech.com/orfclones. FEATURES Location/Qualifiers source 1..1047 /db_xref="H-InvDB:HIT000266770" /organism="Homo sapiens" /mol_type="mRNA" /db_xref="taxon:9606" /clone="GH01528X1.0" /clone_lib="BD Creator(TM) CDS Library derived from MGC collection" /lab_host="DH5alpha T1 resistant" /note="Vector: pDNR-Dual" CDS 1..1047 /note="Mutations: 528:OK;1046:OK" /codon_start=1 /product="Putative prostate cancer tumor suppressor" /protein_id="AAV38805.1" /translation="MGARGAPSRRRQAGRRLRYLPTGSFPFLLLLLLLCIQLGGGQKK KENLLAEKVEQLMEWSSRRSIFRMNGDKFRKFIKAPPRNYSMIVMFTALQPQRQCSVC RQANEEYQILANSWRYSSAFCNKLFFSMVDYDEGTDVFQQLNMNSAPTFMHFPPKGRP KRADTFDLQRIGFAAEQLAKWIADRTDVHIRVFRPPNYSGTIALALLVSLVGGLLYLR RNNLEFIYNKTGWAMVSLCIVFAMTSGQMWNHIRGPPYAHKNPHNGQVSYIHGSSQAQ FVAESHIILVLNAAITMGMVLLNEAATSKGDVGKRRIICLVGLGLVVFFFSFLLSIFR SKYHGYPYSDLDFE" BASE COUNT 260 a 236 c 257 g 294 t ORIGIN 1 atgggggccc ggggcgctcc ttcacgccgt aggcaagcgg ggcggcggct gcggtacctg 61 cccaccggga gctttccctt ccttctcctg ctgctgctgc tctgcatcca gctcggggga 121 ggacagaaga aaaaggagaa tcttttagct gaaaaagtag agcagctgat ggaatggagt 181 tccagacgct caatcttccg aatgaatggt gataaattcc gaaaatttat aaaggcacca 241 cctcgaaact attccatgat tgttatgttc actgctcttc agcctcagcg gcagtgttct 301 gtgtgcaggc aagctaatga agaatatcaa atactggcga actcctggcg ctattcatct 361 gctttttgta acaagctctt cttcagtatg gtggactatg atgaggggac agacgttttt 421 cagcagctca acatgaactc tgctcctaca ttcatgcatt ttcctccaaa aggcagacct 481 aagagagctg atacttttga cctccaaaga attggatttg cagctgaaca actagcaaag 541 tggattgctg acagaacgga tgttcatatt cgggttttca gaccacccaa ctactctggt 601 accattgctt tggccctgtt agtgtcgctt gttggaggtt tgctttattt gagaaggaac 661 aacttggagt tcatctataa caagactggt tgggccatgg tgtctctgtg tatagtcttt 721 gctatgactt ctggccagat gtggaaccat atccgtggac ctccatatgc tcataagaac 781 ccacacaatg gacaagtgag ctacattcat gggagcagcc aggctcagtt tgtggcagaa 841 tcacacatta ttctggtact gaatgccgct atcaccatgg ggatggttct tctaaatgaa 901 gcagcaactt cgaaaggcga tgttggaaaa agacggataa tttgcctagt gggattgggc 961 ctggtggtct tcttcttcag ttttctactt tcaatatttc gttccaagta ccacggctat 1021 ccttatagtg atctggactt tgagtag //